Granulocyte colony-stimulating factor for the treatment of cardiovascular diseases: An update with a critical...

Area of Science:

• Cardiology
• Regenerative Medicine
• Stem Cell Therapy

Background:

• Heart failure and myocardial infarction lead to high mortality and morbidity.
• Conventional treatments are insufficient for severe cases, necessitating advanced therapies like stem cell transplantation.
• Stem cell therapy offers a promising approach to repair injured myocardium, potentially reducing costs and risks associated with current treatments.

Purpose of the Study:

• To review current evidence on granulocyte colony-stimulating factor (G-CSF) in preclinical and clinical settings for myocardial repair.
• To explore the potential of G-CSF as a novel therapeutic strategy for cardiovascular diseases.
• To provide a rationale for future clinical applications of G-CSF in treating damaged heart muscle.

Main Methods:

• Review of preclinical studies investigating G-CSF's effects on stem cell mobilization and differentiation.
• Analysis of available clinical data on G-CSF therapy in patients with heart conditions.
• Synthesis of evidence to evaluate the efficacy and potential mechanisms of G-CSF in myocardial repair.

Main Results:

• Preclinical data and limited clinical evidence suggest G-CSF can mobilize stem cells from bone marrow.
• G-CSF may induce differentiation of mobilized stem cells into cardiomyocytes and endothelial cells.
• The clinical benefits of G-CSF for damaged myocardium remain under investigation and subject to expert debate.

Conclusions:

• G-CSF demonstrates potential in preclinical models for promoting myocardial repair through stem cell mobilization and differentiation.
• Further robust clinical trials are essential to establish the efficacy and safety of G-CSF therapy for heart failure and myocardial infarction.
• G-CSF represents an intriguing therapeutic avenue that warrants continued investigation for cardiovascular regenerative medicine.